Matinas BioPharma

United States · 34 Employees
Matinas BioPharma (NYSE AMER: MTNB) is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology. The Company is developing its own internal portfolio of products as well as partnering with leading pharmaceutical companies to develop novel formulations that capitalize on the unique characteristics of the LNC platform. Preclinical and clinical data have demonstrated that this novel technology can provide solutions to many of the challenges in achieving safe and effective intracellular delivery, for both small molecules and larger, more complex molecules, such as mRNA, DNA plasmids, antisense oligonucleotides, and vaccines. The combination of a unique mechanism of action and flexibility with formulation and route of administration (including oral), positions Matinas' LNC technology to potentially become the preferred next-generation intracellular drug delivery vehicle with distinct advantages over both lipid nanoparticles and viral vectors.

概述

国家 United States
成立时间 2011
总部 1545 US-206 Suite 302, Bedminster Township, NJ 07921, EE. UU.
电话号码 +1 908-443-1860
网站 http://www.matinasbiopharma.com
LinkedIn http://www.linkedin.com/company/matinas-biopharma
Twitter https://twitter.com/MatinasBio
Facebook https://www.facebook.com/matinasbiopharma
员工数 34
行业 research,
简介 Matinas BioPharma (NYSE AMER: MTNB) is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology. The Company is developing its own internal portfolio of products as well as partnering with leading pharmaceutical companies to develop novel formulations that capitalize on the unique characteristics of the LNC platform. Preclinical and clinical data have demonstrated that this novel technology can provide solutions to many of the challenges in achieving safe and effective intracellular delivery, for both small molecules and larger, more complex molecules, such as mRNA, DNA plasmids, antisense oligonucleotides, and vaccines. The combination of a unique mechanism of action and flexibility with formulation and route of administration (including oral), positions Matinas' LNC technology to potentially become the preferred next-generation intracellular drug delivery vehicle with distinct advantages over both lipid nanoparticles and viral vectors.

技术

Amazon AWS

Hosting

Apache

Load Balancers

Google Font API

Fonts

Google Tag Manager

Tag Management

Mobile Friendly

Other

Outlook

Email Providers

Remote

Other

reCAPTCHA

Captcha

常见问题

Matinas BioPharma 在哪里?

Matinas BioPharma 的总部位于 1545 US-206 Suite 302, Bedminster Township, NJ 07921, EE. UU.

Matinas BioPharma 的电话号码是多少?

Matinas BioPharma 的电话号码是 +1 908-443-1860

Matinas BioPharma 的官方网站是什么?

Matinas BioPharma 的公司官方网站是 http://www.matinasbiopharma.com

Matinas BioPharma 是做什么的?

Matinas BioPharma 的业务有哪些?

Matinas BioPharma 的年收入是多少?

Matinas BioPharma 的收入是 4284000美元

Matinas BioPharma 有多少员工?

Matinas BioPharma 有 34 名员工

Matinas BioPharma 属于哪个行业?

Matinas BioPharma 从事以下行业: research

Matinas BioPharma 使用什么技术?

Matinas BioPharma 使用的一些流行技术包括: Amazon AWS,Apache,Google Font API,Google Tag Manager,Mobile Friendly,Outlook,Remote,reCAPTCHA

如何联系 Matinas BioPharma?

Matinas BioPharma 联系信息: 电话号码:+1 908-443-1860, 网站:http://www.matinasbiopharma.com, 邮箱:apa***@***.com

Matinas BioPharma 的社交媒体链接是什么?

Matinas BioPharma 领英:http://www.linkedin.com/company/matinas-biopharma,fackbook:https://www.facebook.com/matinasbiopharma ,twitte:https://twitter.com/MatinasBio

Matinas BioPharma 是一家上市公司吗?

是的,Matinas BioPharma是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:MTNB

Matinas BioPharma 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Matinas BioPharma?

Matinas BioPharma 有 0 家投资者,包括 。

管理层

Anant Patel

Sr. Director, Drug Product Development

Laura Northrup

CMC Program Manager

Abdel Fawzy

Co-Founder and Executive VP

Frank Calamusa

Sr. Vice President, Manufacturing & Supply Chain

员工

Pauline McKay

Executive Assistant

Eugene Dank

Scientist Analytical Development

Gerardo Zelaya

Manufacturing Operator

Pulkit Patel

Drug Product Development Scientist

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google